SOCS3 promotes interleukin-17 expression of human T cells.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-11-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2011-11-392738PMID 23033269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.

  2012cited by this paper
• Aiolos promotes TH17 differentiation by directly silencing Il2 expression

  2012cited by this paper
• Aberrant IL-4 production by SOCS3-over-expressing T cells during infection with Leishmania major exacerbates disease manifestations.

  2011cited by this paper
• IL-7 Promotes TH1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis

  2011cited by this paper
• The many faces of Th17 cells.

  2011cited by this paper
• Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.

  2011cited by this paper
• IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.

  2011cited by this paper
• T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma.

  2011cited by this paper
• Mouse T helper 17 phenotype: not so different than in man after all.

  2011cited by this paper
• Genetic proof for the transient nature of the Th17 phenotype

  2010cited by this paper
• Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage.

  2010cited by this paper
• CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC

  2010cited by this paper
• TGF-β Promotes Th17 Cell Development through Inhibition of SOCS31

  2009cited by this paper
• Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

  2009cited by this paper
• Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

  2009cited by this paper
• Late developmental plasticity in the T helper 17 lineage.

  2009cited by this paper
• SOCS3 in T and NKT Cells Negatively Regulates Cytokine Production and Ameliorates ConA-Induced Hepatitis1

  2009cited by this paper
• A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.

  2008cited by this paper
• Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins

  2008cited by this paper
• Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor

  2008cited by this paper
• Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.

  2008cited by this paper
• Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF.

  2008cited by this paper
• Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1

  2007cited by this paper
• SOCS proteins, cytokine signalling and immune regulation

  2007cited by this paper
• Clonal Expansion of CD8+ Effector T Cells in Childhood Tuberculosis1

  2007cited by this paper
• STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses

  2007cited by this paper
• Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis.

  2007cited by this paper
• Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1

  2007cited by this paper
• Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.

  2007cited by this paper
• Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1

  2006cited by this paper
• Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells.

  2006cited by this paper
• Stat5a Inhibits IL-12-Induced Th1 Cell Differentiation through the Induction of Suppressor of Cytokine Signaling 3 Expression1

  2005cited by this paper
• The N-terminal Truncated Isoform of SOCS3 Translated from an Alternative Initiation AUG Codon under Stress Conditions Is Stable Due to the Lack of a Major Ubiquitination Site, Lys-6*

  2003cited by this paper
• SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses

  2003cited by this paper
• A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production

  2003cited by this paper
• SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta2 subunit.

  2003cited by this paper
• Suppressor of Cytokine Signaling 3 Regulates Proliferation and Activation of T-helper Cells*

  2003cited by this paper
• IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

  2003cited by this paper
• Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range

  2002cited by this paper
• Suppressors of Cytokine Signaling Proteins Are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance

  2002cited by this paper
• Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.

  2001cited by this paper
• Selective expression of a novel surface molecule by human Th2 cells in vivo.

  1999cited by this paper
• SOCS-3 Is Tyrosine Phosphorylated in Response to Interleukin-2 and Suppresses STAT5 Phosphorylation and Lymphocyte Proliferation

  1999cited by this paper
• A Third-Generation Lentivirus Vector with a Conditional Packaging System

  1998cited by this paper
• A family of cytokine-inducible inhibitors of signalling

  1997cited by this paper
• Two forms of rat liver histone H3

  1976cited by this paper

• SOCS3: An Immunological Biomarker Offering Potential Therapeutic Targets for Malignant Tumors

  2025cites this paper
• Resolving the field: a role for Nod2 in T cells.

  2025cites this paper
• High common‐γ cytokine receptor levels promote expression of Interleukin‐2/Interleukin‐7 receptor α‐chains with implications on T‐cell differentiation and function

  2024influential citation
• Signaling networks controlling ID and E protein activity in T cell differentiation and function

  2022cites this paper
• Metabolic plasticity and regulation of T cell exhaustion

  2022cites this paper
• MECHANISMS OF CADMIUM-INDUCED AND EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-DRIVEN LUNG TUMORIGENESIS

  2021cites this paper
• IL-12 and IL-23—Close Relatives with Structural Homologies but Distinct Immunological Functions

  2020cites this paper
• E4BP4-mediated inhibition of T follicular helper cells is compromised in autoimmune disease.

  2020cites this paper
• Suppressor of cytokine signalling 3 is crucial for interleukin‐7 receptor re‐expression after T‐cell activation and interleukin‐7 dependent proliferation

  2020cites this paper
• Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients

  2019cites this paper
• Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis

  2018cites this paper
• The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases

  2018cites this paper
• Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients

  2018cites this paper
• Group 2 ILCs: A way of enhancing immune protection against human helminths?

  2017cites this paper
• Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis

  2017cites this paper
• Prognostic significance of SOCS3 and its biological function in colorectal cancer.

  2017cites this paper
• New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy

  2016cites this paper
• Methylation and microRNA-mediated epigenetic regulation of SOCS3

  2015cites this paper
• Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

  2014cites this paper
• Phosphorylated STAT3 and PD‐1 regulate IL‐17 production and IL‐23 receptor expression in Mycobacterium tuberculosis infection

  2014cites this paper
• Dysregulation of the suppressor of cytokine signalling 3–signal transducer and activator of transcription‐3 pathway in the aetiopathogenesis of Sjögren's syndrome

  2014cites this paper
• Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

  2014cites this paper
• A Negative Feedback Loop Mediated by STAT3 Limits Human Th17 Responses

  2014cites this paper
• Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras

  2013cites this paper
• Étude transcriptomique des cellules dendritiques CD103+ CD4+ chez le rat transgénique HLA-B27, modèle de la spondylarthrite

  2013cites this paper
• Molecular signatures of T-cell inhibition in HIV-1 infection

  2013cites this paper
• Decreased Expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4+ T Cells and Peripheral Blood from Tuberculosis Patients

  2013cites this paper
• Involvement of lymphocytes in asthma and allergic diseases: a genetic point of view

  2013cites this paper
• Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges

  2013cites this paper
• A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

  2013cites this paper